Legend Current Ratio

Stocks . USA . 
Stock . Legend BiotechCorp
LEGN Stock  USD 48.22  0.22  0.46%   
Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
As of 1st of April 2023, Current Ratio is likely to drop to 3.60.

Legend Current Ratio Analysis

Legend BiotechCorp's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Legend BiotechCorp Current Ratio

3.6

Current Ratio 
 = 
Current Asset 
Current Liabilities 
More About Current Ratio | All Equity Analysis

Current Legend BiotechCorp Current Ratio

    
  3.83 X  
Most of Legend BiotechCorp's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Current Ratio. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.
Click cells to compare fundamentals

Legend Current Ratio Historical Pattern

Today, most investors in Legend BiotechCorp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Legend BiotechCorp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Legend BiotechCorp current ratio as a starting point in their analysis.
   Legend BiotechCorp Current Ratio   
       Timeline  
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

Legend Net Cash Flow from Operations

Net Cash Flow from Operations

(184.3 Million)

Legend BiotechCorp Net Cash Flow from Operations is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Net Cash Flow from Operations of (179.58 Million)
In accordance with the recently published financial statements, Legend BiotechCorp has a Current Ratio of 3.83 times. This is 31.62% higher than that of the Healthcare sector and 45.29% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 77.31% lower than that of the firm.

Legend Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.
Legend BiotechCorp is currently under evaluation in current ratio category among related companies.

Legend Fundamentals

Return On Equity(0.97) %
Return On Asset(0.26) %
Operating Margin(3.29) %
Current Valuation8.02 B
Shares Outstanding167.4 M
Shares Owned by Insiders1.36 %
Shares Owned by Institutions38.67 %
Number of Shares Shorted5.11 M
Price to Book19.80 X
Price to Sales73.18 X
Revenue89.79 M
Gross Profit91.56 M
EBITDA(385.31 M)
Net Income(386.21 M)
Cash and Equivalents791.26 M
Cash per Share5.11 X
Total Debt120.46 M
Debt to Equity0.29 %
Current Ratio3.83 X
Book Value Per Share3.63 X
Cash Flow from Operations(198.47 M)
Short Ratio9.52 X
Earnings Per Share(3.14) X
Target Price70.89
Number of Employees1.07 K
Beta-0.0875
Market Capitalization7.85 B
Total Asset1.12 B
Z Score39.0
Net Asset1.12 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2023
Current Ratio 3.89  3.60 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14) 
Revenue Per Share
0.788
Quarterly Revenue Growth
(0.42) 
Return On Assets
(0.26) 
Return On Equity
(0.97) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY